Cue Biopharma Inc (CUE)
1.03
-0.06
(-5.50%)
USD |
NASDAQ |
Nov 21, 16:00
1.04
+0.01
(+0.97%)
After-Hours: 20:00
Cue Biopharma Price: 1.03 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 1.09 | 1.095 | 1.02 | 1.03 | 486484.0 |
| Nov 20, 2024 | 1.11 | 1.170 | 1.050 | 1.09 | 409350.0 |
| Nov 19, 2024 | 1.10 | 1.19 | 1.04 | 1.08 | 1.121M |
| Nov 18, 2024 | 1.25 | 1.37 | 1.05 | 1.10 | 465470.0 |
| Nov 15, 2024 | 1.50 | 1.560 | 1.24 | 1.245 | 1.209M |
| Nov 14, 2024 | 1.58 | 1.60 | 1.45 | 1.50 | 1.330M |
| Nov 13, 2024 | 1.71 | 1.84 | 1.46 | 1.50 | 529619.0 |
| Nov 12, 2024 | 1.88 | 1.915 | 1.61 | 1.70 | 569097.0 |
| Nov 11, 2024 | 1.70 | 1.989 | 1.69 | 1.87 | 907511.0 |
| Nov 08, 2024 | 1.79 | 1.87 | 1.64 | 1.72 | 558659.0 |
| Nov 07, 2024 | 1.65 | 1.90 | 1.59 | 1.78 | 834615.0 |
| Nov 06, 2024 | 1.76 | 1.89 | 1.56 | 1.65 | 790620.0 |
| Nov 05, 2024 | 1.48 | 1.735 | 1.323 | 1.71 | 818954.0 |
| Nov 04, 2024 | 1.51 | 1.64 | 1.45 | 1.49 | 430274.0 |
| Nov 01, 2024 | 1.65 | 1.69 | 1.425 | 1.52 | 579700.0 |
| Oct 31, 2024 | 1.72 | 1.740 | 1.480 | 1.61 | 670216.0 |
| Oct 30, 2024 | 1.71 | 1.899 | 1.69 | 1.75 | 592400.0 |
| Oct 29, 2024 | 1.75 | 1.95 | 1.60 | 1.69 | 781912.0 |
| Oct 28, 2024 | 1.46 | 1.86 | 1.46 | 1.78 | 861271.0 |
| Oct 25, 2024 | 1.54 | 1.63 | 1.31 | 1.48 | 885463.0 |
| Oct 24, 2024 | 1.63 | 1.68 | 1.50 | 1.56 | 475663.0 |
| Oct 23, 2024 | 1.60 | 1.61 | 1.50 | 1.57 | 370042.0 |
| Oct 22, 2024 | 1.68 | 1.68 | 1.50 | 1.60 | 696847.0 |
| Oct 21, 2024 | 1.33 | 1.899 | 1.281 | 1.68 | 5.537M |
| Oct 18, 2024 | 1.15 | 1.23 | 1.10 | 1.21 | 320744.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.4541
Minimum
Sep 26 2024
30.73
Maximum
Jun 02 2020
8.250
Average
4.30
Median
Apr 27 2023
Price Benchmarks
| Biomarin Pharmaceutical Inc | 63.45 |
| Arbutus Biopharma Corp | 3.46 |
| GlycoMimetics Inc | 0.32 |
| FibroGen Inc | 0.3872 |
| Cidara Therapeutics Inc | 17.45 |
Price Related Metrics
| PS Ratio | 5.351 |
| Price to Book Value | 2.572 |
| Earnings Yield | -88.35% |
| Market Cap | 65.25M |